Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 136
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01987986 | A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy | ||
| NCT00266214 | Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome | ||
| NCT04236635 | Histopathology Following CCH Injection | ||
| NCT01086150 | Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy | ||
| NCT01430169 | Pharmacokinetics of a Single Treatment Cycle of AA4500 0.58 mg in Men With Peyronie's Disease | ||
| NCT05419505 | Study of Different Interventions to Reduce Bruising Following CCH-Aaes Treatment for Cellulite of the Buttocks | ||
| NCT00904397 | Lidocaine Patch 5% Versus Celecoxib 200 mg in Chronic Axial Low Back Pain | ||
| NCT00574860 | EN3285 for the Prevention or Delay of Oral Mucositis in Patients With Head and Neck Cancer | ||
| NCT01498640 | Retreatment of Recurrent Dupuytren's Contractures | ||
| NCT05026216 | To Assess the Effectiveness of Multiple Dose, Multiple Concentrations of Qwo, for the Treatment of Mild to Moderate Cellulite. | ||
| NCT00700128 | Prevention of Menstrual Migraines: Using Frovatriptan or Placebo During Hormone Free Intervals | ||
| NCT00652093 | Lumbar Stenosis Outcomes Research II | ||
| NCT00884715 | Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome | ||
| NCT00904449 | Open Label Assessment of Long-Term Safety and Utility | ||
| NCT04381117 | Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH) | ||
| NCT02687451 | Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects | ||
| NCT00904085 | Post-operative Efficacy and Safety Study | ||
| NCT00801398 | Open-Label Safety and Tolerability Study of Oxymorphone for Acute Postoperative Pain in Pediatric Subjects. | ||
| NCT01310803 | Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | ||
| NCT00779103 | Histrelin Subcutaneous Implant in Children With Central Precocious Puberty | ||
| NCT03767452 | Additional Xiaflex® Treatment in Patients With Peyronie's Disease Recurrence, Worsening, or Incomplete Response | ||
| NCT00528424 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Advanced Dupuytren's Disease | ||
| NCT00945919 | A Pilot Study of Ultra Rapid Opioid Rotation and Titration of Oxymorphone | ||
| NCT01715467 | CORRECT: COmmunity RegistRy Study Evaluating Dupuytren's Contracture Treatment | ||
| NCT00522431 | A Study of Fortigel Testosterone Gel 2% in Males With Low Testosterone | ||
| NCT00904605 | Lidocaine Patch Versus Celecoxib in Pain From Osteoarthritis of the Knee | ||
| NCT00370981 | Exploratory Study of Pagoclone in Men With Premature Ejaculation. | ||
| NCT01689896 | Testosterone and Pain Sensitivity | ||
| NCT00904475 | Pilot Study of the Efficacy and Safety of Lidoderm Patch in the Treatment of Low Back Pain | ||
| NCT00216255 | EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study | ||
| NCT00904111 | A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain | ||
| NCT06169319 | A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA) | ||
| NCT00528606 | AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture | ||
| NCT05873595 | Real-World Data Study to Understand Effectiveness of Treatments in Peyronie's Disease | ||
| NCT01606345 | Phase I Study of Percutaneous Valrubicin for Upper Tract Urothelial Carcinoma | ||
| NCT01221597 | Study of AA4500 in the Treatment of Peyronie's Disease | ||
| NCT01518907 | The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) | ||
| NCT03518034 | A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal Men | ||
| NCT05877066 | Real-World Data Study to Understand Participant Treatment Outcomes for Dupuytren's Contracture | ||
| NCT01685437 | A Phase 3, Open-label Study of the Safety and Effectiveness of AA4500 Administered Twice Per Treatment Cycle for up to Four Treatment Cycles (2 x 4) in Men With Peyronie's Disease | ||
| NCT00637572 | Evaluate Weight Gain Using 2 Different Formulations of Megestrol Acetate Oral Suspension for AIDS-related Weight Loss | ||
| NCT04209530 | Impact of CCH Treatment of Buttock and Thigh Cellulite in Adult Women | ||
| NCT03446781 | Effectiveness and Safety of EN3835 in the Treatment of Cellulite in Women | ||
| NCT00414453 | Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis | ||
| NCT00911287 | Oxymorphone Extended Release (ER) in Opioid-Naive Patients With Chronic Pain | ||
| NCT00226421 | Efficacy and Safety of Oxymorphone Extended Release in Opioid-Experienced Patients With Chronic Non-Malignant Pain | ||
| NCT01243411 | A Study of AA4500 in Men With Peyronie's Disease | ||
| NCT04580303 | CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques | ||
| NCT00904462 | Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee | ||
| NCT00262106 | Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection |
